CL
CLVS

CSS LLC’s Clovis Oncology, Inc. CLVS Stock Holding History

CSS LLC’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,600
Closed -$34K – 1457
2021
Q4 		$34K Hold
12,600
– – ﹤0.01% 1129
2021
Q3 		$56K Hold
12,600
– – ﹤0.01% 1052
2021
Q2 		$73K Buy
+12,600
New +$73.8K ﹤0.01% 963
2020
Q2 		– Sell
-4,600
Closed -$29K – 783
2020
Q1 		$29K Sell
4,600
-3,500
-43% -$28.1K ﹤0.01% 550
2019
Q4 		$84K Sell
8,100
-16,900
-68% -$123K ﹤0.01% 572
2019
Q3 		$98K Buy
+25,000
New +$202K 0.01% 507
2019
Q2 		– Sell
-13,000
Closed -$322K – 877
2019
Q1 		$322K Buy
13,000
+10,000
+333% +$251K 0.02% 364
2018
Q4 		$54K Sell
3,000
-5,000
-63% -$102K ﹤0.01% 491
2018
Q3 		$235K Buy
8,000
+6,000
+300% +$232K 0.01% 407
2018
Q2 		$91K Sell
2,000
-5,500
-73% -$267K ﹤0.01% 483
2018
Q1 		$396K Sell
7,500
-19,300
-72% -$1.13M 0.02% 337
2017
Q4 		$1.82M Buy
26,800
+1,300
+5% +$90.9K 0.09% 161
2017
Q3 		$2.1M Buy
25,500
+8,500
+50% +$674K 0.1% 151
2017
Q2 		$1.59M Buy
17,000
+6,400
+60% +$392K 0.08% 181
2017
Q1 		$674K Buy
+10,600
New +$644K 0.04% 283

Other funds holding CLVS

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

CSS LLC's CLVS Position: Q2 2021 in Review

CSS LLC sold out of Clovis Oncology, Inc. (CLVS) in Q2 2021, closing a stake of 6,000 shares — an estimated $35.2K sold.

CSS LLC first reported a position in CLVS in Q4 2016 and held it in 7 quarters. The position peaked at $277K in Q2 2020. 160 funds tracked by Wall St. Rank hold CLVS as of Q2 2021.

  • CSS LLC reported no remaining Clovis Oncology, Inc. position as of Q2 2021 after selling out during the quarter.
  • CSS LLC sold 6,000 Clovis Oncology, Inc. shares in Q2 2021, an estimated $35.2K.
  • CSS LLC first reported a position in Clovis Oncology, Inc. in Q4 2016 and held it in 7 quarters.
  • CSS LLC's Clovis Oncology, Inc. position peaked at $277K in Q2 2020.
  • 160 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2021.

Based on CSS LLC's 13F filing for Q2 2021, filed 16 Aug 2021.